Clearstead Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$739K Buy
10,709
+6,996
+188% +$483K 0.14% 85
2025
Q1
$258K Buy
3,713
+436
+13% +$30.3K 0.06% 135
2024
Q4
$282K Buy
3,277
+2,098
+178% +$180K 0.06% 128
2024
Q3
$140K Hold
1,179
0.03% 159
2024
Q2
$168K Hold
1,179
0.04% 142
2024
Q1
$151K Buy
1,179
+105
+10% +$13.5K 0.04% 156
2023
Q4
$111K Buy
1,074
+16
+2% +$1.66K 0.03% 191
2023
Q3
$96.2K Buy
1,058
+150
+17% +$13.6K 0.03% 178
2023
Q2
$72.3K Hold
908
0.02% 189
2023
Q1
$72.3K Hold
908
0.02% 197
2022
Q4
$61K Hold
908
0.02% 222
2022
Q3
$45K Hold
908
0.02% 215
2022
Q2
$51K Hold
908
0.04% 120
2022
Q1
$50K Sell
908
-202
-18% -$11.1K 0.03% 125
2021
Q4
$62K Hold
1,110
0.04% 126
2021
Q3
$53K Buy
+1,110
New +$53K 0.03% 133
2017
Q3
Sell
-3,000
Closed -$64K 226
2017
Q2
$64K Buy
+3,000
New +$64K 0.05% 150